A detailed history of Fifth Third Bancorp transactions in Abbott Laboratories stock. As of the latest transaction made, Fifth Third Bancorp holds 1,293,811 shares of ABT stock, worth $150 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
1,293,811
Previous 1,302,069 0.63%
Holding current value
$150 Million
Previous $135 Million 9.02%
% of portfolio
0.54%
Previous 0.52%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$100.07 - $118.13 $826,378 - $975,517
-8,258 Reduced 0.63%
1,293,811 $148 Million
Q2 2024

Jul 22, 2024

BUY
$100.73 - $112.44 $358,195 - $399,836
3,556 Added 0.27%
1,302,069 $135 Million
Q1 2024

Apr 23, 2024

BUY
$109.52 - $120.96 $7.28 Million - $8.04 Million
66,488 Added 5.4%
1,298,513 $148 Million
Q4 2023

Jan 19, 2024

BUY
$90.19 - $110.4 $7.47 Million - $9.15 Million
82,849 Added 7.21%
1,232,025 $136 Million
Q3 2023

Oct 31, 2023

BUY
$95.53 - $114.62 $2.39 Million - $2.87 Million
25,025 Added 2.23%
1,149,176 $111 Million
Q2 2023

Jul 25, 2023

BUY
$100.78 - $112.29 $1.71 Million - $1.91 Million
16,966 Added 1.53%
1,124,151 $123 Million
Q1 2023

Apr 24, 2023

SELL
$96.86 - $114.01 $6.67 Million - $7.86 Million
-68,909 Reduced 5.86%
1,107,185 $112 Million
Q4 2022

Jan 25, 2023

SELL
$95.06 - $111.52 $535,853 - $628,638
-5,637 Reduced 0.48%
1,176,094 $0
Q3 2022

Oct 25, 2022

BUY
$96.76 - $112.03 $8.08 Million - $9.36 Million
83,515 Added 7.6%
1,181,731 $114 Million
Q2 2022

Aug 04, 2022

SELL
$102.07 - $123.37 $2.18 Million - $2.63 Million
-21,355 Reduced 1.91%
1,098,216 $119 Million
Q1 2022

Apr 19, 2022

SELL
$114.02 - $139.04 $606,358 - $739,414
-5,318 Reduced 0.47%
1,119,571 $133 Million
Q4 2021

Feb 01, 2022

BUY
$115.53 - $141.46 $43,208 - $52,906
374 Added 0.03%
1,124,889 $158 Million
Q3 2021

Oct 15, 2021

SELL
$116.66 - $129.06 $2.66 Million - $2.94 Million
-22,768 Reduced 1.98%
1,124,515 $133 Million
Q2 2021

Aug 06, 2021

SELL
$105.79 - $124.53 $7.75 Million - $9.12 Million
-73,246 Reduced 6.0%
1,147,283 $133 Million
Q1 2021

May 07, 2021

BUY
$108.84 - $128.23 $2.05 Million - $2.41 Million
18,803 Added 1.56%
1,220,529 $146 Million
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $1.7 Million - $1.86 Million
16,227 Added 1.37%
1,201,726 $132 Million
Q3 2020

Nov 09, 2020

SELL
$91.64 - $111.29 $3.98 Million - $4.83 Million
-43,396 Reduced 3.53%
1,185,499 $129 Million
Q2 2020

Aug 05, 2020

BUY
$76.57 - $98.0 $3.16 Million - $4.05 Million
41,322 Added 3.48%
1,228,895 $112 Million
Q1 2020

May 05, 2020

BUY
$62.82 - $91.86 $1,067 - $1,561
17 Added 0.0%
1,187,573 $93.7 Million
Q4 2019

Feb 14, 2020

SELL
$78.51 - $87.4 $100,178 - $111,522
-1,276 Reduced 0.11%
1,187,556 $103 Million
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $4.39 Million - $4.76 Million
53,603 Added 4.72%
1,188,832 $99.5 Million
Q2 2019

Aug 07, 2019

SELL
$72.88 - $85.0 $524,808 - $612,085
-7,201 Reduced 0.63%
1,135,229 $95.5 Million
Q1 2019

May 14, 2019

BUY
$66.22 - $80.06 $1.61 Million - $1.94 Million
24,277 Added 2.17%
1,142,430 $91.3 Million
Q4 2018

Feb 14, 2019

SELL
$65.56 - $74.27 $2.86 Million - $3.24 Million
-43,630 Reduced 3.76%
1,118,153 $80.9 Million
Q3 2018

Nov 14, 2018

BUY
$60.81 - $73.36 $1.91 Million - $2.3 Million
31,392 Added 2.78%
1,161,783 $85.2 Million
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $1.95 Million - $2.15 Million
33,817 Added 3.08%
1,130,391 $68.9 Million
Q1 2018

May 15, 2018

BUY
$56.27 - $63.62 $3.42 Million - $3.86 Million
60,746 Added 5.86%
1,096,574 $65.7 Million
Q4 2017

Feb 14, 2018

BUY
$53.68 - $57.47 $694,511 - $743,546
12,938 Added 1.26%
1,035,828 $59.1 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $2.23 Million - $2.49 Million
46,485 Added 4.76%
1,022,890 $54.6 Million
Q2 2017

Aug 11, 2017

BUY
N/A
976,405
976,405 $47.5 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.